424.23
price up icon0.29%   1.24
after-market Dopo l'orario di chiusura: 423.48 -0.75 -0.18%
loading
Precedente Chiudi:
$422.99
Aprire:
$425.7
Volume 24 ore:
376.41K
Relative Volume:
1.00
Capitalizzazione di mercato:
$9.42B
Reddito:
-
Utile/perdita netta:
$-518.67M
Rapporto P/E:
-16.89
EPS:
-25.12
Flusso di cassa netto:
$-438.32M
1 W Prestazione:
-3.57%
1M Prestazione:
-0.15%
6M Prestazione:
+27.08%
1 anno Prestazione:
+98.33%
Intervallo 1D:
Value
$419.41
$428.25
Intervallo di 1 settimana:
Value
$419.41
$452.00
Portata 52W:
Value
$200.63
$457.16

Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile

Name
Nome
Madrigal Pharmaceuticals Inc
Name
Telefono
404-380-9263
Name
Indirizzo
200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA
Name
Dipendente
528
Name
Cinguettio
@MadrigalPharma
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
MDGL's Discussions on Twitter

Confronta MDGL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MDGL
Madrigal Pharmaceuticals Inc
424.23 9.43B 0 -518.67M -438.32M -25.12
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
385.74 97.91B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.90 58.88B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
446.40 58.93B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
711.62 43.52B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
326.06 36.11B 3.81B -644.79M -669.77M -6.24

Madrigal Pharmaceuticals Inc Stock (MDGL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-09-04 Ripresa H.C. Wainwright Buy
2025-02-28 Aggiornamento B. Riley Securities Neutral → Buy
2025-02-27 Reiterato H.C. Wainwright Buy
2024-06-28 Iniziato Cantor Fitzgerald Neutral
2024-06-11 Iniziato Wolfe Research Outperform
2024-04-22 Iniziato BofA Securities Underperform
2024-03-15 Aggiornamento B. Riley Securities Sell → Neutral
2024-03-06 Iniziato Citigroup Buy
2024-02-26 Downgrade B. Riley Securities Neutral → Sell
2022-12-20 Reiterato Oppenheimer Outperform
2022-12-19 Reiterato H.C. Wainwright Buy
2022-12-19 Reiterato Piper Sandler Overweight
2022-12-19 Aggiornamento Raymond James Underperform → Mkt Perform
2022-07-08 Downgrade B. Riley Securities Buy → Neutral
2021-10-07 Iniziato Jefferies Buy
2021-08-06 Aggiornamento BMO Capital Markets Market Perform → Outperform
2021-05-20 Ripresa Goldman Buy
2020-11-24 Ripresa Evercore ISI Outperform
2020-11-06 Reiterato H.C. Wainwright Buy
2020-07-31 Iniziato Piper Sandler Overweight
2020-06-05 Iniziato BMO Capital Markets Market Perform
2020-05-05 Iniziato Chardan Capital Markets Buy
2020-01-30 Iniziato Canaccord Genuity Buy
2020-01-09 Aggiornamento UBS Neutral → Buy
2019-11-07 Reiterato H.C. Wainwright Buy
2019-06-25 Iniziato Stifel Hold
2019-06-10 Aggiornamento B. Riley FBR Neutral → Buy
2019-02-28 Reiterato H.C. Wainwright Buy
2019-02-22 Iniziato SVB Leerink Outperform
2019-01-23 Iniziato UBS Neutral
2018-12-14 Iniziato Wolfe Research Outperform
2018-12-12 Iniziato B. Riley FBR Neutral
2018-11-19 Downgrade Raymond James Mkt Perform → Underperform
2018-11-16 Aggiornamento Evercore ISI In-line → Outperform
2018-09-04 Iniziato Citigroup Buy
2018-08-06 Downgrade Goldman Buy → Neutral
2018-06-28 Iniziato Raymond James Mkt Perform
Mostra tutto

Madrigal Pharmaceuticals Inc Borsa (MDGL) Ultime notizie

pulisher
04:30 AM

What drives Madrigal Pharmaceuticals Inc YDO1 stock priceHigh Frequency Trading Trends & Small Budget Capital Investment - Early Times

04:30 AM
pulisher
11:00 AM

What drives Madrigal Pharmaceuticals Inc stock priceSupport and Resistance Levels & Rapid Capital Trading - Early Times

11:00 AM
pulisher
Sep 27, 2025

Madrigal Pharmaceuticals Announces Positive Quality of Life Outcomes for Rezdiffra in NASH Treatment - MSN

Sep 27, 2025
pulisher
Sep 27, 2025

What analysts say about Madrigal Pharmaceuticals Inc stockSupport Zone Identification & Unlock Long-Term Capital Growth Ideas - Early Times

Sep 27, 2025
pulisher
Sep 27, 2025

Madrigal Pharmaceuticals Inc Stock Analysis and ForecastAutomated Trading Signals & Low Entry Capital Stocks - Early Times

Sep 27, 2025
pulisher
Sep 25, 2025

Madrigal Pharmaceuticals (MDGL) Gets a Buy from UBS - The Globe and Mail

Sep 25, 2025
pulisher
Sep 23, 2025

Strs Ohio Acquires Shares of 1,900 Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

Sep 23, 2025
pulisher
Sep 21, 2025

Madrigal Pharmaceuticals Grants Equity Awards to 76 New Employees - MSN

Sep 21, 2025
pulisher
Sep 21, 2025

Analyst Downgrade: Is Madrigal Pharmaceuticals Inc. affected by consumer sentimentSell Signal & Consistent Profit Trading Strategies - خودرو بانک

Sep 21, 2025
pulisher
Sep 20, 2025

Fund Flows: Is Diana Shipping Inc vulnerable to short sellers2025 Major Catalysts & Technical Buy Zone Confirmations - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Treasury Yields: Will Madrigal Pharmaceuticals Inc. outperform during market ralliesQuarterly Portfolio Summary & Growth Focused Entry Point Reports - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Bond Watch: Can Madrigal Pharmaceuticals Inc weather a recessionOptions Play & Safe Capital Growth Plans - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Leadership Changes at Madrigal Pharmaceuticals Mark New Phase of Growth - MSN

Sep 20, 2025
pulisher
Sep 19, 2025

How to read the order book for Madrigal Pharmaceuticals Inc.Profit Target & AI Enhanced Trading Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Value Recap: Can Madrigal Pharmaceuticals Inc stock double in the next year2025 Institutional Moves & Real-Time Market Sentiment Alerts - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Smart Money: What is Madrigal Pharmaceuticals Incs TAM Total Addressable MarketJuly 2025 Closing Moves & Daily Oversold Stock Bounce Ideas - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Growth Value: Does ENERR have pricing powerJuly 2025 Final Week & Weekly Watchlist for Consistent Profits - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Sep 19, 2025
pulisher
Sep 19, 2025

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Sep 19, 2025
pulisher
Sep 19, 2025

Madrigal Pharmaceuticals gains amid takeover speculation - MSN

Sep 19, 2025
pulisher
Sep 18, 2025

Madrigal Pharmaceuticals Reports Strong 2024 Growth Fueled by Rezdiffra Launch - MSN

Sep 18, 2025
pulisher
Sep 18, 2025

Madrigal Pharmaceuticals announces grants of inducement awards - MarketScreener

Sep 18, 2025
pulisher
Sep 18, 2025

76 New Hires: Madrigal Pharmaceuticals Awards 31.8K RSUs and Stock Options in MASH Drug Expansion - Stock Titan

Sep 18, 2025
pulisher
Sep 18, 2025

Investment Report: What are Madrigal Pharmaceuticals Incs recent SEC filings showingBull Run & Daily Profit Focused Screening - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Intech Investment Management LLC Purchases 1,696 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

Sep 18, 2025
pulisher
Sep 17, 2025

Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - MarketBeat

Sep 17, 2025
pulisher
Sep 17, 2025

EP Wealth Advisors LLC Makes New Investment in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

Sep 17, 2025
pulisher
Sep 17, 2025

Rhumbline Advisers Acquires 1,924 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

Sep 17, 2025
pulisher
Sep 16, 2025

Market Overview: Can Madrigal Pharmaceuticals Inc weather a recession2025 Volume Leaders & Safe Capital Growth Stock Tips - khodrobank.com

Sep 16, 2025
pulisher
Sep 16, 2025

Madrigal (MDGL) Secures $500M to Fuel MASH Pipeline Expansion - MSN

Sep 16, 2025
pulisher
Sep 16, 2025

Growth Value: Will Madrigal Pharmaceuticals Inc outperform during market ralliesJuly 2025 Big Picture & Fast Gaining Stock Strategy Reports - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Earnings Recap: Is Madrigal Pharmaceuticals Inc benefiting from innovation trendsStop Loss & Fast Entry and Exit Trade Plans - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Market Review: What are Madrigal Pharmaceuticals Incs earnings expectationsEarnings Growth Summary & Weekly High Conviction Trade Ideas - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Pullback Watch: Is Madrigal Pharmaceuticals Inc stock good for income investors2025 Technical Patterns & Daily Growth Stock Tips - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Madrigal stock jumps 13% after Rezdiffra Q3 sales beat estimates - MSN

Sep 16, 2025
pulisher
Sep 15, 2025

Downgrade Watch: What is the next catalyst for ATEXWeekly Gains Summary & Technical Confirmation Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Aug PostEarnings: Is Madrigal Pharmaceuticals Inc stock forming a cup and handleLayoff News & Technical Buy Zone Confirmation - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Short Squeeze: How is Capital City Bank Group Inc. managing supply chain issuesPortfolio Risk Report & Daily Stock Momentum Reports - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Recap Report: Does Madrigal Pharmaceuticals Inc. stock benefit from AI growthJuly 2025 Patterns & Weekly Consistent Profit Watchlists - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Woodline Partners LP Raises Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat

Sep 15, 2025
pulisher
Sep 14, 2025

Madrigal Pharmaceuticals (NASDAQ:MDGL) CEO Sells $3,243,740.77 in Stock - MarketBeat

Sep 14, 2025
pulisher
Sep 14, 2025

Assessing Madrigal Pharmaceuticals (MDGL) Valuation After Rezdiffra’s Strong Q2 Sales and EU Approval - Sahm

Sep 14, 2025
pulisher
Sep 14, 2025

Canaccord Genuity Group Forecasts Strong Price Appreciation for Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock - Defense World

Sep 14, 2025
pulisher
Sep 14, 2025

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Sep 14, 2025
pulisher
Sep 13, 2025

Madrigal Pharmaceuticals stock price target raised by Canaccord on MASH drug outlook - Investing.com Canada

Sep 13, 2025
pulisher
Sep 13, 2025

Madrigal Pharmaceuticals (NASDAQ:MDGL) Reaches New 12-Month HighTime to Buy? - MarketBeat

Sep 13, 2025
pulisher
Sep 12, 2025

What is HC Wainwright's Estimate for MDGL Q3 Earnings? - MarketBeat

Sep 12, 2025
pulisher
Sep 12, 2025

Canaccord Genuity Boosts Madrigal Pharmaceuticals (MDGL) Price T - GuruFocus

Sep 12, 2025

Madrigal Pharmaceuticals Inc Azioni (MDGL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Madrigal Pharmaceuticals Inc Azioni (MDGL) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Sibold William John
President and CEO
Sep 09 '25
Sale
445.63
7,279
3,243,741
102,474
$20.95
price up icon 3.41%
$82.70
price up icon 1.27%
$29.07
price up icon 0.80%
$98.08
price up icon 0.00%
$137.03
price up icon 1.06%
biotechnology ONC
$326.06
price down icon 0.81%
Capitalizzazione:     |  Volume (24 ore):